Skip Navigation

Research Funding

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

June 2014 DAIDS Council-Approved Concepts

Concepts represent early planning stages for program announcements, request for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to the Opportunities and Announcements portal.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Integrated Preclinical/Clinical Program for HIV Microbicides and Biomedical Prevention (IPCP-MBP)

For the published request for applications, see the June 4, 2014 Guide announcement, Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP) (U19).

Increased Knowledge and Innovative Strategies to Reduce HIV Incidence—iKnow Projects

Request for Applications

Contact: David Burns

Objectives:

  • To promote innovative research to improve our ability to identify populations that are both at high risk of HIV-1 infection and have a high proportion of people that are unaware of their HIV status.
  • To successfully link them to HIV testing, effective prevention interventions, and, if HIV-positive, care and treatment.

Description: Applications may include phylogenetic studies, social and sexual network analyses, mathematical modeling, and studies to examine the acceptability and feasibility of new prevention interventions in the populations and settings identified. Research projects that integrate multiple approaches to achieve these objectives will be strongly encouraged. Mathematical modeling may be proposed to augment phylogenetic and network studies, as well as to examine the potential impact of new interventions. Applications will address the following objectives:

  1. Devise optimal strategies to identify people unaware of their HIV infection in specific high-risk populations and settings.
  2. Increase uptake of HIV testing and linkage to prevention services, care, and treatment in these populations.
  3. Develop and examine the feasibility and acceptability of integrated biomedical and behavioral interventions that substantially reduce the likelihood of onward HIV transmission in these populations.

Adherence to ARV-Based Treatment and Prevention

For the published request for applications, see the December 1, 2014 Guide announcement, Innovative Measures of Oral Medication Adherence for HIV Treatment and Prevention (R01).

Targeting Persistent HIV Reservoirs (TaPHIR)

For the published program announcement with special receipt, referral and/or review considerations, see the November 20, 2014 Guide announcement, Targeting Persistent HIV Reservoirs (TaPHIR) (R21/R33).

U.S.-China Program for Research Toward a Cure for HIV/AIDS

For the published request for applications, see the July 16, 2014 Guide announcement, U.S.-China Program for Research Toward a Cure for HIV/AIDS (R01).

Staged Vaccine Development

For the published broad agency announcement, see the June 3, 2015 solicitation, Staged Vaccine Development.

HIV Vaccine Research and Design (HIVRAD)

For the published program announcement with special receipt, referral and/or review considerations, see the March 31, 2015 Guide announcement, HIV Vaccine Research and Design (HIVRAD) Program (P01).

Mechanisms of Immune Protection From TB Among HIV-Infected Individuals

For the published request for applications, see the March 26, 2015 Guide announcement, Mechanisms of Immune Protection From TB Among HIV-Infected Individuals (R01).

Limited Competition: Strategic Timing of Antiretroviral Treatment (START)

For the published program announcement with special receipt, referral and/or review considerations, see the August 29, 2014 Guide announcement, Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1).

Inhaled Delivery of Clofazimine (CFZ)—An Important Antituberculosis Drug

For the published request for proposals, see the August 15, 2014 Solicitation of the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.

Simple, Inexpensive Unit for Removing Cells From Small Amounts of Blood in Resource-Limited Settings

For the published request for proposals, see the August 15, 2014 Solicitation of the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.​​​​

Last Updated June 16, 2015

Last Reviewed November 20, 2014